Etomidate
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Etomidate and local guidelines before prescribing.
Intravenous anaesthetic
Mechanism
GABA-A potentiator intravenous anaesthetic.
Uses
Induction in haemodynamically unstable patients.
Dosing
- Induction — ketamine (1–2 mg/kg — haemodynamically safer in shock), propofol (1–2.5 mg/kg — reduced doses in unstable patients), thiopental (traditional for obstetric RSI), etomidate (adrenal suppression — not routinely in UK); often with fentanyl.
Anaesthesia: Airway management and anaesthetic drugs - Etomidate | GABA-A; 0.3 mg/kg | Cardiovascular stability | Adrenal suppression (11β-hydroxylase inhibition) — avoided in sepsis; myoclonus, PONV
Anaesthesia: Airway management and anaesthetic drugs
Side effects
Adrenal suppression, myoclonus, nausea, injection pain.
Interactions
Few.
Contraindications and cautions
Adrenal insufficiency
Monitoring
BP
Pregnancy and breastfeeding
Use if needed
Renal and hepatic impairment
Caution in hepatic impairment
Overdose and reversal
Supportive
Special advice
Cardiovascular stable; single dose only because of adrenal suppression.
More from the textbook: uses, cautions and other points
- Cushing's syndrome (before surgery or if surgery isn't possible) - metyrapone and osilodrostat (block cortisol synthesis - risk of adrenal insufficiency and low potassium/high blood pressure from precursor build-up), ketoconazole (liver toxicity - specialist), etomidate IV in severe cases.
Endocrine: Anatomy Physiology and Pharmacology - Steroidogenesis inhibitors: Metyrapone, osilodrostat, ketoconazole (liver monitoring), IV etomidate in critical cases.
Endocrinology: Adrenal Disease - Etomidate , ketoconazole, metyrapone | Adrenal suppression
Endocrine: Anatomy Physiology and Pharmacology - Primary (adrenal failure - Addison's disease) | Autoimmune (about 80–90% in the UK); TB (commonest worldwide); adrenal haemorrhage (anticoagulants, meningococcal sepsis, antiphospholipid syndrome); metastases (lung, breast, melanoma); bilateral adrenalectomy; drugs (ketoconazole, metyrapone, osilodrostat, etomidate, mitotane); …
Endocrinology: Adrenal Disease - Urgent medical control of cortisol: Metyrapone, osilodrostat or ketoconazole; IV etomidate in severe cases.
Endocrinology: Adrenal Disease - Drugs: Etomidate (an induction agent) briefly suppresses cortisol production.
Endocrinology: Adrenal Disease - Adrenal-blocking drugs: Ketoconazole, metyrapone, osilodrostat, etomidate and mitotane reduce cortisol production. Mitotane also increases hydrocortisone requirements.
Endocrinology: Adrenal Disease - Unconsciousness - IV induction (propofol, thiopental, ketamine, etomidate) then maintenance with volatile gases (sevoflurane, desflurane) or a propofol infusion.
Surgery: Surgical principles and perioperative care
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (5 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (6 mentions)